FITLIFE BRANDS, INC. Annual Report - How They Did This Year

I’ve put together this guide to help you understand how FitLife Brands performed this year. My goal is to break down the company’s filings so you can see the big picture without the confusing financial jargon.

1. What does this company do?

FitLife Brands develops, markets, and sells nutritional supplements. They own several brands, including NDS, iSatori, Dr. Tobias, MusclePharm, and the recently acquired Irwin Naturals. They sell products through specialty stores like GNC, online giants like Amazon, and major retailers like Walmart, Costco, and CVS. The company acts as a brand manager, outsourcing manufacturing to keep their business model lean.

2. Financial performance

The company is in a major transition. Total revenue grew 26% to $81.5 million in 2025. However, profit dropped 30% to $6.3 million.

This profit decline stems from the $42.5 million acquisition of Irwin Naturals. This deal brought higher costs, including $1.2 million in professional and restructuring fees. Additionally, Irwin’s products have lower profit margins. Essentially, the company is trading short-term profit to gain a larger footprint in physical retail stores.

3. Major wins and challenges this year

• The Big Win: The $42.5 million acquisition of Irwin Naturals in August 2025 is the headline story. This deal added over 100 products and significantly expanded their shelf space at Walmart and Costco.
• Innovation: They are refreshing their lineup aggressively. They launched 36 new products or flavors in 2025, up from 23 in 2024, focusing on trending categories like sleep and digestive health.
• Stock Split: To make shares more accessible to retail investors, they completed a 2-for-1 stock split in February 2025. This doubled the number of shares held by investors.

4. Financial health

To fund the Irwin acquisition, the company took out a $44.7 million loan. To protect against rising interest rates, they locked in a fixed interest rate of 6.25%.

A note on margins: Profit margins on sales fell from 43.6% in 2024 to 38.6% in 2025. This drop happened because Irwin’s products are less profitable and the company spent more on promotions to secure premium shelf space in national stores.

5. Key risks that could hurt the stock price

• The "Amazon" Risk: Amazon remains a critical sales channel. Online sales dropped from 67% of total revenue in 2024 to 51% in 2025. Any changes to Amazon’s fees or search rankings could impact cash flow.
• Debt & Control: The $44.7 million loan comes with strict rules, including a limit on how much debt they can carry relative to their earnings. If they miss these targets, lenders could demand immediate repayment.
• Quality & Regulation: Because they use outside manufacturers, they face supply chain risks. If a partner fails to follow safety rules, the company could face product recalls or legal trouble from the FDA and FTC.

6. Competitive positioning

FitLife is evolving from a niche player into a mass-market powerhouse. They are currently cutting costs to improve efficiency. For example, they closed their Canadian office in late 2025, which should save about $850,000 per year.

7. Future outlook

The company is focused on integrating Irwin Naturals to save $2 million by the end of 2026. They plan to stop selling Irwin’s CBD products to focus on faster-growing supplements. Management aims to stabilize profit margins by streamlining their supply chain and using their larger size to negotiate better prices with manufacturers.

Investor Takeaway: FitLife is currently in a "growth over profit" phase. They are betting that the scale gained from the Irwin Naturals acquisition will eventually lead to higher efficiency and better margins. When deciding whether to invest, consider if you believe their strategy to move from online-only to big-box retail will pay off, and keep a close eye on their ability to manage the debt taken on to fund that transition.